Articles by Jane Wan - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jane Wan

Jane Wan


Jane Wan is a freelance writer based in Singapore.

Articles
Brunei's Potential Pharmaceutical Market Growth
June 2, 2014

Brunei harnesses its rich biodiversity and the growing halal market in a bid to develop its pharmaceutical sector.

Pharma Industry Corruption in China Under Scrutiny
April 1, 2014

China's regulatory and compliance environment is set to change as the government declares a crackdown on bribery scandals.

Regulators Get Tough on Corruption in China
March 2, 2014

China's regulatory and compliance environment is set to change as the government declares a crackdown on bribery scandals.

Clinical Trials Head East to Asia
December 2, 2013

The rising cost of drug development and the decreasing proportion of drug-naive population in the US and European markets are driving international pharmaceutical companies to consider emerging markets as a location to conduct their clinical trials. Asia stands out among the emerging markets given its double-digit growth rates.

Report from Myanmar
October 2, 2013

Foreign companies zero in on Myanmar with the hope of securing a foothold in its pharmaceutical market.

Report from India
August 2, 2013

Industry players brace themselves to face challenges as India's new drug-pricing policy kicks in full gear.

Report from Taiwan
June 2, 2013

The Taiwanese government engages in regulatory science in a move to boost its pharmaceutical sector.

Report from Thailand
April 2, 2013

The Thai government is ramping up efforts to promote and develop the biotechnology sector in a bid to enhance its global competitiveness.

Report from India
February 2, 2013

Quality assurance of biological products is central to India's good distribution practices guidelines.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What impact do mega-mergers of biopharmaceutical companies have on the development of new drugs?
Improves the quality and number of innovative drugs available to patients.
Restricts innovation and the development of new drugs.
Has no impact on drug development.
Do not know.
Improves the quality and number of innovative drugs available to patients.
29%
Restricts innovation and the development of new drugs.
54%
Has no impact on drug development.
4%
Do not know.
13%
Eric Langer Outsourcing Outlook Eric LangerOutsourcing No Longer Just for Cost-Cutting
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerSeeking Alternative Catalyst Solutions
Jill Wechsler Regulatory Watch Jill Wechsler Global Expansion Shapes Drug Oversight
Chris Burgess Statistical Solutions Chris BurgessIs a Sample Size of n=6 a Magic Number?
Sean Milmo European Regulatory WatchSean MilmoRegulating the Environmental Impact of Pharmaceuticals
FindPharma Custom Search
Click here